Sunshine Biopharma Inc. Acquisitions, Net of Cash Acquired
Sunshine Biopharma Inc. (SBFM) reported Acquisitions, Net of Cash Acquired of $0 for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2019-11-13
- Sunshine Biopharma Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2019-09-30 was $0.00.
- Sunshine Biopharma Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2019-06-30 was $0.00.
- Sunshine Biopharma Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2018-09-30 was -$85.23K.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month |
|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $0.00 derived: sum of 2 quarters · filed 2019-11-13 | $0.00 10-Q · filed 2019-11-13 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-15 | $0.00 10-Q · filed 2019-08-15 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-20 | ||
| 2018-09-30 | -$85.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$85.23K derived: sum of 2 quarters · filed 2019-11-13 | -$4.94K 10-Q · filed 2019-11-13 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-15 | $80.29K 10-Q · filed 2019-08-15 | |
| 2018-03-31 | $80.29K 10-Q · filed 2019-05-20 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |